Treatment of a senescence-associated ocular disease or disorder using a Bcl-xL selective inhibitor
US-12285427-B2 · Apr 29, 2025 · US
This page is not indexed by search engines while we improve data quality.
David Nathaniel patents
David Nathaniel is listed as an inventor on 67 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | David Nathaniel |
| Total patents | 67 |
| First publication | Nov 24, 2016 |
| Latest publication | Apr 29, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Treating liver disease by selectively eliminating senescent cells
US-11980616-B2 · May 14, 2024 · US
Treating cardiovascular disease by selectively eliminating senescent cells
US-11963957-B2 · Apr 23, 2024 · US
Treatment of a Senescence-Associated Ocular Disease or Disorder Using a Bcl-xL Selective Inhibitor
US-2024115563-A1 · Apr 11, 2024 · US
Methods of inhibiting pathological angiogenesis
US-11865123-B2 · Jan 9, 2024 · US
Treating cognitive decline and other neurodegenerative conditions by selectively removing senescent cells from neurological tissue
US-11351167-B2 · Jun 7, 2022 · US
Treatment of parkinson's disease and other conditions caused or mediated by senescent astrocytes using small molecule senolytic agents
US-2022096466-A1 · Mar 31, 2022 · US
Methods of Inhibiting Pathological Angiogenesis
US-2022072015-A1 · Mar 10, 2022 · US
Methods of inhibiting pathological angiogenesis
US-11129838-B2 · Sep 28, 2021 · US
Treating cardiovascular disease by selectively eliminating senescent cells
US-2021169875-A1 · Jun 10, 2021 · US
Recent patents
Latest publications not already listed above.
Treating liver disease by selectively eliminating senescent cells
US-2021169876-A1 · Jun 10, 2021 · US
Treating cognitive decline and other neurodegenerative conditions by selectively removing senescent cells from neurological tissue
US-2021030752-A1 · Feb 4, 2021 · US
Composition comprising a gene vector that selectively depletes p16 positive senescent cells
US-2020370029-A1 · Nov 26, 2020 · US
Treatment of Lung Diseases Using Pharmaceutical Agents that Eliminate Senescent Cells
US-2020354336-A9 · Nov 12, 2020 · US
Use of a Heterocyclic Bcl-xL Inhibitor and Related Analogs for Removing Senescent Cells in the Treatment of Eye Diseases and Other Age-Related Conditions
US-2020338094-A1 · Oct 29, 2020 · US
Use of a heterocyclic bcl-2 inhibitor for removing senescent cells and treating senescence-associated conditions
US-2020338097-A1 · Oct 29, 2020 · US
Methods of Inhibiting Pathological Angiogenesis
US-2020253991-A1 · Aug 13, 2020 · US
Treatment of Lung Diseases Using Pharmaceutical Agents that Eliminate Senescent Cells
US-2020199103-A1 · Jun 25, 2020 · US
Technology to inhibit vascular changes that lead to vision loss in the eye
US-10588916-B2 · Mar 17, 2020 · US
Chemical entities that kill senescent cells for use in treating age-related disease
US-2020069703-A1 · Mar 5, 2020 · US
Composition comprising a gene vector that selectively depletes P16 positive senescent cells
US-10550378-B2 · Feb 4, 2020 · US
Treating cognitive decline and other neurodegenerative conditions by selectively removing senescent cells from neurological tissue
US-2020030323-A1 · Jan 30, 2020 · US
Removing senescent cells from a mixed cell population or tissue using a phosphoinositide 3-kinase (PI3K) inhibitor
US-10517866-B2 · Dec 31, 2019 · US
Compositions of matter for treatment of ophthalmic conditions by selectively removing senescent cells from the eye
US-10478432-B2 · Nov 19, 2019 · US
Unit dose of an aryl sulfonamide that is effective for treating eye disease and averting potential vision loss
US-10478433-B2 · Nov 19, 2019 · US
Therapy for removing senescent cells and treating senescence-associated disease using an mdm2 inhibitor
US-2019343832-A1 · Nov 14, 2019 · US
Composition comprising a gene vector that selectively depletes p16 positive senescent cells
US-2019316109-A1 · Oct 17, 2019 · US
Chemical entities that kill senescent cells for use in treating age-related disease
US-10426788-B2 · Oct 1, 2019 · US
Methods and compositions for killing senescent cells and for treating senescence-associated diseases and disorders using an inhibitor of Akt kinase
US-10413542-B2 · Sep 17, 2019 · US
Treatment of parkinson's disease and other conditions caused or mediated by senescent astrocytes using small molecule senolytic agents
US-2019269675-A1 · Sep 5, 2019 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Unity Biotechnology Inc | 68 |
| Buck Inst Res Aging | 43 |
| Mayo Found Medical Education & Res | 35 |
| Univ Johns Hopkins | 16 |
| Buck Inst For Res On Aging | 7 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K31/496 | 54 |
| A61K9/0019 | 53 |
| A61K9/0048 | 50 |
| A61P27/02 | 48 |
| A61P9/10 | 47 |